Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P20226 (
TATA-binding protein
)
1,297
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
CpG island promoters often lack canonical core promoter elements such as the TATA box, and have dispersed transcription initiation sites. Despite the prevalence of CpG islands associated with mammalian genes, the mechanism of transcription initiation from CpG island promoters remains to be clarified. Here we investigate the mechanism of transcription initiation of the CpG island-associated gene, insulin-degrading enzyme (IDE). IDE is ubiquitously expressed, and has dispersed transcription initiation sites. The IDE core promoter locates within a 32-bp region, which contains three CGGCG repeats and a
nuclear respiratory factor 1
(
NRF-1
) binding motif. Sequential mutation analysis indicates that the
NRF-1
binding motif is critical for IDE transcription initiation. The
NRF-1
binding motif is functional, because
NRF-1
binds to this motif in vivo and this motif is required for the regulation of IDE promoter activity by
NRF-1
. Furthermore, the
NRF-1
binding site in the IDE promoter is conserved among different species, and dominant negative
NRF-1
represses endogenous IDE expression. Finally,
TATA-box binding protein
(
TBP
) is not associated with the IDE promoter, and inactivation of
TBP
does not abolish IDE transcription, suggesting that
TBP
is not essential for IDE transcription initiation. Our studies indicate that
NRF-1
mediates IDE transcription initiation in a
TBP
-independent manner, and provide insights into the potential mechanism of transcription initiation for other CpG island-associated genes.
...
PMID:Nuclear respiratory factor 1 mediates the transcription initiation of insulin-degrading enzyme in a TATA box-binding protein-independent manner. 2287 Feb 79